Of note, the PD-1Neg CD8+ T cell subset included antigen-specific cells with effector and memory-precursor-like phenotype, with effector and proliferative capacity.38 In addition, it has been demonstrated that checkpoint blockade can act on different immune cells within the TME to stimulate anti-tumor CD8+ T cell responses.39,40. Here, CD8A is linked to neoplasm.